Investors
Presentations & Videos
For investor-related information please contact Ronn Bechler at Market Eye
Ph: +61 3 9591 8901 E: ronn.bechler@marketeye.com.au
2021
See more
https://zeliratx.stevenwright.com.au/presentations/Proactiveinvestors_AU_-_Zelira_Therapeutics_commercialisation_program_to_see_launch_of_suite_of_new_cannabinoid-based_prod.pdf

Zelira Therapeutics’ commercialisation program
Zelira to launch a suite of new cannabinoid-based products in FY22 – Proactive
August 10, 2021
https://www.youtube.com/watch?v=muhK--qz0hY
Channel 9 News Perth
Zelira Therapeutics and Curtin University partner on research of proprietary technology that demonstrates significant uptake of CBD into the brain
August 7, 2021
https://zeliratx.stevenwright.com.au/presentations/Zelira_Therapeutics-Cantor_Presentation-June_29_2021.pdf

Presentation at Cantor Fitzgerald International Cannabis Forum
Zelira Therapeutics Investor Slide Deck
June 10, 2021
2020
See more
https://www.youtube.com/watch?v=to0cJZkeXNM
Proactive – Zelira Therapeutics forms exclusive licensing deal to distribute its HOPE products in Washington DC
Zelira Therapeutics forms exclusive licensing deal to distribute its HOPE products in Washington DC
December 18, 2020
https://www.youtube.com/watch?v=eipQrkRxw_0
Proactive – Zelira Therapeutics and Emyria team up for ‘disruptive’ autism spectrum disorder trial
Some excerpt
November 9, 2020
https://clients3.weblink.com.au/pdf/ZLD/02296985.pdf

2019
See more
https://www.youtube.com/watch?v=6LZLvRG9CeM
Proactive Interview – Zelira Therapeutics on its acquisition with Ilera
December 3, 2019
https://zeliratx.com/wp-content/uploads/2019/10/CFN-Media-Interviews-Zelda-Therapeutics-at-New-West-Summit2-Mp4-Video-1280x720-5-.mp4

https://zeliratx.com/wp-content/uploads/2019/10/Zelda-Therapeutics-Investor-Teleconference-10002468-161019.mp3
2018
See more
https://www.youtube.com/watch?v=W4qXsc9jeok
Zelda Therapeutics poised to ‘value add al the way from clinical trails to the market’.
December 2, 2018
https://www.youtube.com/watch?v=W4qXsc9jeok
Zelda Therapeutics poised to ‘value add all the way from clinical trails to the market’
December 2, 2018
https://zeliratx.stevenwright.com.au/presentations/Investor_Presentation_Nondeal_RoadshowNOV2018.pdf

2017
See more
https://zeliratx.stevenwright.com.au/presentations/Preso_Nov2017.pdf

https://zeliratx.stevenwright.com.au/presentations/Preso_Feb2017.pdf

2016
See more
https://zeliratx.stevenwright.com.au/presentations/Preso_Nov2016.pdf

2015
See more
https://zeliratx.stevenwright.com.au/presentations/Preso_Dec2015.pdf
